苑东生物
(688513)
| 流通市值：104.95亿 | | | 总市值：104.95亿 |
| 流通股本：1.77亿 | | | 总股本：1.77亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,019,133,615.33 | 654,448,569.46 | 305,640,342.42 | 1,349,755,302.66 |
| 营业收入 | 1,019,133,615.33 | 654,448,569.46 | 305,640,342.42 | 1,349,755,302.66 |
| 二、营业总成本 | 830,690,066.9 | 546,061,623.3 | 259,521,097.68 | 1,161,906,337.64 |
| 营业成本 | 247,736,615.83 | 158,324,672.33 | 63,711,307.96 | 338,445,876.86 |
| 税金及附加 | 15,422,976.39 | 9,314,921.08 | 4,182,466.28 | 20,990,079.9 |
| 销售费用 | 320,484,840.52 | 207,061,311.82 | 110,616,491.3 | 445,787,301.63 |
| 管理费用 | 68,492,411.71 | 45,209,217.52 | 21,742,223.94 | 107,145,595.11 |
| 研发费用 | 183,301,396.13 | 129,497,447.96 | 61,097,854.94 | 263,855,882.16 |
| 财务费用 | -4,748,173.68 | -3,345,947.41 | -1,829,246.74 | -14,318,398.02 |
| 其中:利息费用 | 1,890,937.16 | 1,275,243.07 | 720,341.73 | 3,682,764.05 |
| 其中:利息收入 | 6,966,483.68 | 4,681,846.93 | 2,606,210.22 | 17,541,463.48 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 13,338,891.52 | 6,835,167.13 | 3,436,962.88 | 14,923,057.38 |
| 加:投资收益 | 2,496,953.1 | 4,047,937.64 | 1,021,187.84 | 9,841,891.62 |
| 资产处置收益 | 24,531.82 | - | - | -2,992.06 |
| 资产减值损失(新) | -3,786,009.34 | -1,079,831.19 | -804,911.88 | -5,698,289.79 |
| 信用减值损失(新) | -1,940,618.28 | -512,876.13 | 2,803.4 | -3,052,666.28 |
| 其他收益 | 43,178,294.68 | 31,947,529.47 | 12,693,796.74 | 48,120,498.3 |
| 四、营业利润 | 241,755,591.93 | 149,624,873.08 | 62,469,083.72 | 251,980,464.19 |
| 加:营业外收入 | 433,650.02 | 193,478.09 | 9,793.09 | 1,388,875 |
| 减:营业外支出 | 99,433 | 80,894.27 | 66,326.56 | 781,030.96 |
| 五、利润总额 | 242,089,808.95 | 149,737,456.9 | 62,412,550.25 | 252,588,308.23 |
| 减:所得税费用 | 21,927,326.29 | 13,165,530.82 | 1,822,198.61 | 14,354,148.93 |
| 六、净利润 | 220,162,482.66 | 136,571,926.08 | 60,590,351.64 | 238,234,159.3 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 220,162,482.66 | 136,571,926.08 | 60,590,351.64 | 238,234,159.3 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 220,162,482.66 | 136,571,926.08 | 60,590,351.64 | 238,234,159.3 |
| 扣除非经常损益后的净利润 | 172,996,071.09 | 103,809,982.23 | 46,468,704.84 | 174,764,929.24 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.25 | 0.77 | 0.34 | 1.36 |
| (二)稀释每股收益 | 1.25 | 0.77 | 0.34 | 1.36 |
| 九、综合收益总额 | 220,162,482.66 | 136,571,926.08 | 60,590,351.64 | 238,234,159.3 |
| 归属于母公司股东的综合收益总额 | 220,162,482.66 | 136,571,926.08 | 60,590,351.64 | 238,234,159.3 |
| 公告日期 | 2025-10-28 | 2025-08-19 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |